Cardiome Announces XYDALBA™ Single Dose Infusion Approval by European Medicines Agency

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. ENOV
7. AON
8. BLSM
9. AZN
10. EIX

Go back to Cardiome Announces XYDALBA™ Single Dose Infusion Approval by European Medicines Agency

Cardiome Pharma (CRME) Misses Q2 EPS by 18c

August 9, 2016 5:07 PM EDT

Cardiome Pharma (NASDAQ: CRME) reported Q2 EPS of ($0.37), $0.18 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $6.73 million.

For earnings history and earnings-related data on Cardiome Pharma (CRME) click here.

... More